We are testing a new bispecific T-cell receptor treatment for patients with solid tumors. The study looks at its effects alone and with a checkpoint inhibitor to see how well it works.
Health conditions and diseases that the clinical trial is designed to study and treat.
Solid tumors are abnormal masses of tissue that can occur in various organs and are characterized by uncontrolled cell growth. They can be benign (non-cancerous) or malignant (cancerous), leading to various symptoms depending on their location.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.